Yield10 Bioscience Stock Retained Earnings
| YTENDelisted Stock | USD 1.90 0.04 2.06% |
Yield10 Bioscience fundamentals help investors to digest information that contributes to Yield10 Bioscience's financial success or failures. It also enables traders to predict the movement of Yield10 Stock. The fundamental analysis module provides a way to measure Yield10 Bioscience's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Yield10 Bioscience stock.
Yield10 |
Yield10 Bioscience Company Retained Earnings Analysis
Yield10 Bioscience's Retained Earnings is a balance sheet account that refers to the portion of company income that is retained by the firm. In other words, it is a part of earnings that is not paid out as dividends or otherwise distributed to owners. Retained Earnings are calculated by adding net income to last period retained earnings and subtracting any dividends paid to owners.
More About Retained Earnings | All Equity Analysis
Retained Earnings | = | Beginning RE + Income | - | Dividends |
Current Yield10 Bioscience Retained Earnings | (414.15 M) |
Most of Yield10 Bioscience's fundamental indicators, such as Retained Earnings, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Yield10 Bioscience is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Retained Earnings shows how the firm utilizes its profits over time. In simple terms, investors can think of retained earnings as the amount of profit the company has reinvested in the business since its inceptions. However the methodology to make a decision over how much profit to retain is different between companies in different industries. For example, growing industries tend to retain more of their earnings than more matured industries as they need more assets investment to sustain their growth.
CompetitionBased on the latest financial disclosure, Yield10 Bioscience has a Retained Earnings of (414.15 Million). This is 102.16% lower than that of the Biotechnology sector and 134.44% lower than that of the Health Care industry. The retained earnings for all United States stocks is 104.44% higher than that of the company.
Yield10 Retained Earnings Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Yield10 Bioscience's direct or indirect competition against its Retained Earnings to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Yield10 Bioscience could also be used in its relative valuation, which is a method of valuing Yield10 Bioscience by comparing valuation metrics of similar companies.Yield10 Bioscience is currently under evaluation in retained earnings category among its peers.
Yield10 Fundamentals
| Return On Equity | -15.08 | ||||
| Return On Asset | -1.5 | ||||
| Operating Margin | (240.28) % | ||||
| Current Valuation | 3.96 M | ||||
| Shares Outstanding | 642.54 K | ||||
| Shares Owned By Insiders | 12.59 % | ||||
| Shares Owned By Institutions | 11.79 % | ||||
| Number Of Shares Shorted | 60.7 K | ||||
| Price To Earning | (3.19) X | ||||
| Price To Book | 11.23 X | ||||
| Price To Sales | 79.63 X | ||||
| Revenue | 60 K | ||||
| Gross Profit | (7.3 M) | ||||
| EBITDA | (14.13 M) | ||||
| Net Income | (14.46 M) | ||||
| Cash And Equivalents | 10.16 M | ||||
| Cash Per Share | 2.07 X | ||||
| Total Debt | 3.18 M | ||||
| Debt To Equity | 0.28 % | ||||
| Current Ratio | 6.58 X | ||||
| Book Value Per Share | (4.95) X | ||||
| Cash Flow From Operations | (10.07 M) | ||||
| Short Ratio | 0.03 X | ||||
| Earnings Per Share | (43.68) X | ||||
| Target Price | 2.5 | ||||
| Number Of Employees | 29 | ||||
| Beta | 1.7 | ||||
| Market Capitalization | 1.85 M | ||||
| Total Asset | 3.91 M | ||||
| Retained Earnings | (414.15 M) | ||||
| Working Capital | (3.46 M) | ||||
| Current Asset | 15.34 M | ||||
| Current Liabilities | 3.91 M | ||||
| Net Asset | 3.91 M |
About Yield10 Bioscience Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Yield10 Bioscience's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Yield10 Bioscience using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Yield10 Bioscience based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Yield10 Bioscience
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Yield10 Bioscience position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Yield10 Bioscience will appreciate offsetting losses from the drop in the long position's value.Moving against Yield10 Stock
| 0.83 | IPI | Intrepid Potash | PairCorr |
| 0.79 | AA | Alcoa Corp Fiscal Year End 15th of January 2025 | PairCorr |
| 0.78 | IE | Ivanhoe Electric | PairCorr |
| 0.72 | MHGVY | Mowi ASA ADR | PairCorr |
| 0.66 | CTVA | Corteva | PairCorr |
The ability to find closely correlated positions to Yield10 Bioscience could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Yield10 Bioscience when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Yield10 Bioscience - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Yield10 Bioscience to buy it.
The correlation of Yield10 Bioscience is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Yield10 Bioscience moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Yield10 Bioscience moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Yield10 Bioscience can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Your Current Watchlist to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Other Consideration for investing in Yield10 Stock
If you are still planning to invest in Yield10 Bioscience check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Yield10 Bioscience's history and understand the potential risks before investing.
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |